This nanodrug not only effectively overcomes the aforementioned limitations, but also significantly reverses the immunosuppressive effects of adenosine, allowing for improved DC maturation and subsequent activation of CD8+ T cells, which are critical for mounting an effective anti‐tumor immune response. The gene discussed is CD8A; the disease is neoplasm.